This is unfortunate from both financial and human suffering points of view. While ototoxicity is most widely recognized for aminoglycosides and platinumbased anticancer drugs, as well as some nonsteroidal anti-inflammatory agents and loop diurectics, the inherent nature of some effective therapeutic drugs to be both cytotoxic and tissue permeant implies that many FDA-approved drugs may be ototoxic to varying degrees.